For example, several attempts have been made to use genes that are commonly hypermethylated in breast tumors (GSTP1, RASSF1A, RARβ, APC, and DAPK) to generate a blood-based breast cancer methylation signature [108]. This evidence concerns the gene GSTP1 and breast carcinoma.